Machine learning and generative artificial intelligence (AI) have the potential to revolutionize HIV care, but there are lingering doubts about their true impact. At the 2026 Conference on Retroviruses and Opportunistic Infections (CROI), experts discussed the exciting possibilities these technologies offer for improving HIV outcomes. However, questions remain about how exactly these tools will be implemented and what their real-world effects might be. Dr. Ravi Goyal, a moderator at the conference, expressed skepticism, stating, 'We've been told it will revolutionize public health and healthcare, but I'm not sure I fully buy the hype yet. Machine learning and generative AI are impressive in demonstrations and labs, but we need to see if they consistently translate into better patient outcomes.' This sentiment highlights a crucial debate: Are these technologies a shortcut to improved HIV management, or could they potentially short-circuit our progress? The full news story, including insights from the conference and further analysis, can be found here. And don't forget to explore all the aidsmap reports from CROI 2026 for a comprehensive overview of the latest advancements in HIV research.
